Glucagon-like peptide 1 treatment reverses vascular remodelling by downregulating matrix metalloproteinase 1 expression through inhibition of the ERK1/2/NF-B signalling pathway
Kosiborod MN, Petrie MC, Borlaug BA et al (2024) Semaglutide in patients with obesity-related heart failure and type 2 diabetes
Can't wait to go back for more! Sarah K.
GLP-1 medications can contribute to dehydration indirectly if nausea, vomiting, diarrhea, constipation, or reduced appetite lowers fluid intake
Concentration and formulation considerations Higher concentration solutions generally absorb better because they maintain a stronger concentration gradient across the mucosal membrane
And unlike those approaches, GLP-1 therapy under medical supervision has a clinical success rate backed by two decades of research